# Be Clinical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/be-clinical

- Headquarters: New Delhi, India
- Website: www.be-clinical.com/
- Total disclosed funding: $3.1M
- Latest round: Seed (Aug 22, 2026)
- Investors on record: 3

## About

Be Clinical is an innovative skincare company dedicated to developing science-backed anti-aging solutions, particularly known for its PlumpX Serum that enhances skin hydration and texture.Founded by Hemangi Dhir, in 2025, Be Clinical is based in Delhi, India, and specializes in skincare products targeting aging concerns. Be Clinical’s founder has prior experience in the skincare industry, though specific details about past ventures are not available. In August 2026, Be Clinical raised INR 210 million in seed funding led by Sauce.vc, with participation from V3 Ventures. 

Be Clinical offers the PlumpX Serum, its flagship product that contains 1.3% Hyaluronic Acid and 12% Hydroxypropyl Tetrahydropyrantriol. This serum employs multi-molecular hydration technology to effectively penetrate the skin, enhancing hydration, firmness, and overall texture. It primarily targets consumers in the United States, Canada, and select European countries, providing direct-to-consumer sales through its website.

The revenue model of Be Clinical is centered around direct-to-consumer sales of the PlumpX Serum through its online platform. The company generates revenue from both new customers and repeat buyers, capitalizing on a streamlined sales process that emphasizes customer satisfaction and product efficacy. The pricing strategy reflects its positioning as a premium skincare brand.

The company will use the August 2026 funding to enhance its manufacturing and research scale internally.

## Funding rounds

- Seed, Aug 22, 2026, $2.2M — Sauce.vc, V3 Ventures
- Seed, Jan 7, 2026, $0.7M — Titan Capital, V3 Ventures
- Seed, May 13, 2025, $0.2M — Titan Capital

## Investors

- Titan Capital — Seed
- V3 Ventures — Seed
- Sauce.vc (https://capitalatlas.ai/funds/sauce-vc) — Seed